Novel Bis-1,2,3-triazole-thiazolidinone hybrid as anticancer agents that induce apoptosis and molecular modeling study
Future Medicinal Chemistry · 2024
DOI: 10.1080/17568919.2024.2394019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2024. Verfasst von Abdoullah Bimoussa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Organic Synthesis & Physico-Molecular Chemistry, Department of Chemistry, Faculty of Sciences Semlalia, Université Cadi Ayyad, BP PO Bo…. Hauptthemen laut MEDLINE: Triazoles, Antineoplastic Agents, Apoptosis, Thiazolidines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aim: A series of (R)-Carvone-based 1,2,3-triazole-thiazolidinone 17a-h hybrids were synthesized and characterized by spectroscopic techniques NMR and HRMS. The chemical reactivity and the stability parameters were observed via DFT.Method/results: The objective was to evaluate the anticancer activity of the synthesized compounds against cancer cell lines. The mechanism of action by which the 17b and 17g exert their effect suggested that they may induce apoptosis through activation of caspase-3/7. This effect was observed against the most important NIMA-related kinases via Docking investigation. The designed compounds were identified as the best inhibitors of the NEK family via the inactivation of the caspase-3. The Docking results were supported by Dynamics where the binding energies justified the medicinal importance of the synthesized derivatives. [Box: see text].
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Organic Synthesis & Physico-Molecular Chemistry, Department of Chemistry, Faculty of Sciences Semlalia, Université Cadi Ayyad, BP PO Box 2390, Marrakech, 40001, Morocco.
- Laboratory of Organic & Physical Chemistry, Applied Bioorganic Chemistry Team, Faculty of Sciences, Ibnou Zohr University, Agadir, Morocco.
- Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-Kharj, 11942, Saudi Arabia.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The Islamia University of Bahawalpur, 63100, Pakistan.
- BioSpectroscopie Translationnelle, BioSpecT-EA7506, UFR de Pharmacie, Université de Reims Champagne-Ardenne, 51 Rue Cognacq Jay, 51096, Reims Cedex, France.
- Equipe MSO, CNRS UMR 7312 Institut de Chimie Moléculaire Université de Reims Champagne-Ardenne, Bat. Europol'Agro - Moulin de La Housse UFR SciencesB.P.,1039, 51687, Reims Cedex 2, France.
ORCID-Profile: Abdoullah Bimoussa
Zitieren
APA
Bimoussa, A., Oubella, A., Alossaimi, M. A., Aziz, M., Attaullah, H. M., Ejaz, S. A., Morjani, H., Auhmani, A., Robert, A., Riahi, A., Riadi, Y., & Ait Itto, M. Y. (2024). Novel Bis-1,2,3-triazole-thiazolidinone hybrid as anticancer agents that induce apoptosis and molecular modeling study. Future Medicinal Chemistry. https://doi.org/10.1080/17568919.2024.2394019
Vancouver
Bimoussa A, Oubella A, Alossaimi MA, Aziz M, Attaullah HM, Ejaz SA, et al. Novel Bis-1,2,3-triazole-thiazolidinone hybrid as anticancer agents that induce apoptosis and molecular modeling study. Future Medicinal Chemistry. 2024. doi:10.1080/17568919.2024.2394019
BibTeX
@article{Bimoussa2024,
author = {Bimoussa, Abdoullah and Oubella, Ali and Alossaimi, Manal A and Aziz, Mubashir and Attaullah, Hafiz Muhammad and Ejaz, Syeda Abida and Morjani, Hamid and Auhmani, Aziz and Robert, Anthony and Riahi, Abdelkhalek and Riadi, Yassine and Ait Itto, Moulay Youssef},
title = {Novel Bis-1,2,3-triazole-thiazolidinone hybrid as anticancer agents that induce apoptosis and molecular modeling study},
journal = {Future Medicinal Chemistry},
year = {2024},
doi = {10.1080/17568919.2024.2394019}
}
EUVIMED